Metabolic indicators
|
Mean change
|
---|
Soy-nut
|
TSP
|
Control
|
P value
|
---|
TC (mg/dl)
|
− 29.2 ± 3.56a,c
|
− 24.3 ± 3.54a,c
|
− 8.7 ± 5.47
|
< 0.01
|
TG (mg/dl)
|
− 12.2 ± 1.86c
|
− 11.6 ± 1.95c
|
− 4.1 ± 1.12
|
0.14
|
HDL-C (mg/dl)
|
2.1 ± 0.49c
|
1.7 ± 0.64c
|
− 0.57 ± 1.46
|
0.10
|
LDL-C (mg/dl)
|
− 23.1 ± 2.03a,c
|
− 20.1 ± 3.00a,c
|
− 0.80 ± 3.84
|
< 0.001
|
VLDL-C (mg/dl)
|
− 7.1 ± 1.11a,c
|
− 5.0 ± 0.67a,c
|
− 0.37 ± 1.23
|
< 0.001
|
Apo AI (g/l)
|
0.19 ± 0.03a,c
|
0.18 ± 0.03a,c
|
− 0.02. ± 0.01
|
< 0.01
|
Apo B100(g/l)
|
− 0.31 ± 0.04a,c
|
− 0.28 ± 0.01a,c
|
0.06 ± 0.05
|
< 0.001
|
FBG (mg/dl)
|
− 14.4 ± 1.10b,c
|
− 6.5 ± 0.60c
|
− 2.8 ± 1.54
|
< 0.001
|
Insulin (µIU/ml)
|
− 2.0 ± 0.29b,c
|
− 0.8 ± 0.20a,c
|
0.4 ± 0.22
|
< 0.001
|
HOMA-IR
|
− 0.9 ± 0.08b,c
|
− 0.4 ± 0.06a,c
|
− 0.02 ± 0.07
|
< 0.001
|
TG/HDL
|
− 0.5 ± 0.08a,c
|
− 0.4 ± 0.09a,c
|
0.03 ± 0.21
|
< 0.01
|
CRP (µg/ml)
|
− 0.25 ± 0.16
|
− 0.16 ± 0.17
|
− 0.04 ± 0.32
|
0.8
|
Fibrinogen (mg/dl)
|
− 18.8 ± 8.98
|
− 14.5 ± 9.53
|
− 7.8 ± 6.24
|
0.65
|
MDA (µmol/l)
|
− 0.75 ± 0.04a,c
|
− 0.63 ± 0.07a,c
|
− 0.01 ± 0.08
|
< 0.001
|
TAC (µmol/l)
|
214.2 ± 20.02a,c
|
198.0 ± 23.47a,c
|
45.1 ± 19.34
|
< 0.001
|
- Values are mean ± standard error
- TSP: Textured soy protein; SBP: systolic blood pressure; DBP: diastolic blood pressure; TC: total cholesterol; TG: triglyceride; HDL-C: high density lipoprotein; LDL-C: low density lipoprotein; VLDL-C: very low density lipoprotein; Apo AI: apolipoprotein AI; Apo B100: apolipoprotein B100; FBG: fasting blood glucose; HOMA-IR: homeostasis model of assessment insulin resistance; TG/HDL-C: triglyceride/high density lipoprotein; MDA: malondialdehyde; TAC: total antioxidant capacity; CRP: C-reactive protein
- aThere was a significant difference in the treatment groups compared with control group (post hoc ANOVA)
- bThere was a significant difference in the soy-nut group compared with TSP and control groups (post hoc ANOVA)
- cFor significant changes after-before (paired t-test)